XML 97 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Fair Value Measurements

9. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the Codification establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Other inputs that are observable directly or indirectly, such as quoted prices for similar assets and liabilities or market corroborated inputs.

Level 3: Unobservable inputs are used when little or no market data is available and requires the Company to develop its own assumptions about how market participants would price the assets or liabilities. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimizes the use of unobservable inputs to the extent possible as well as considers counterparty and our own credit risk in its assessment of fair value.

 

The following tables present our financial assets and liabilities that are carried at fair value, classified according to the three categories described above (in thousands):

 

     Fair Value Measurement at December 31, 2013  
     Total      Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
     Significant Other
Observable Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 

Assets:

           

Cash equivalents—money market funds

   $ 832       $ 832       $ —        $ —    

Cash equivalents—commercial paper

     8,998         —          8,998         —    

Cash equivalents—corporate bonds

     8,585         —          8,585         —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 18,415       $ 832       $ 17,583       $ —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           

Contingent acquisition consideration

   $ 2,302       $ —        $ —        $ 2,302   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

   $ 2,302       $ —        $ —        $ 2,302   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Fair Value Measurement at December 31, 2012  
     Total      Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
     Significant Other
Observable Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 

Assets:

           

Cash equivalents—money market funds

   $ 1,445       $ 1,445       $ —        $ —    

Cash equivalents—commercial paper

     5,649         —          5,649         —    

Cash equivalents—corporate bonds

     6,330         —          6,330         —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 13,424       $ 1,445       $ 11,979       $ —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           

Contingent acquisition consideration

   $ 2,064       $ —        $ —        $ 2,064   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

   $ 2,064       $ —        $ —        $ 2,064   
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s recurring fair value measures relate to short-term investments, which are classified as cash equivalents and derivative instruments. The fair value of our cash equivalents are either based on quoted prices for similar assets or other observable inputs such as yield curves at commonly quoted intervals and other market corroborated inputs. The fair value of our derivatives is based on quoted market prices from various banking institutions or an independent third party provider for similar instruments. In determining the fair value, we consider our non-performance risk and that of our counterparties. At December 31, 2013, we had one 30-day forward contract outstanding to sell 3.0 million British pounds sterling and one 30-day forward contract outstanding to purchase $5.0 million that together, had an immaterial fair value.

For the recurring fair value measure, contingent acquisition consideration, the Company estimated the fair value of the liability by probability weighting the range of possible achievement of the criteria upon which the contingent consideration to be paid will be determined. The resulting estimated amount was then adjusted to its estimated net present value based upon a present value factor that was derived by applying a risk adjusted discount rate over the applicable contingency period. The increase in the contingent acquisition consideration during 2013 was due to the accretion of the present value of $0.2 million.

 

The Company’s non-financial assets and non-financial liabilities subject to non-recurring measurements include goodwill and intangible assets.